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Abstract
Background
Preventive chemotherapy (PC) with benzimidazole drugs is the backbone of soil-transmitted
helminth (STH) control programs. Over the past decade, drug coverage has increased and
with it, the possibility of developing anthelmintic resistance. It is therefore of utmost impor-
tance to monitor drug efficacy. Currently, a variety of novel diagnostic methods are avail-
able, but it remains unclear whether they can be used to monitor drug efficacy. In this study,
we compared the efficacy of albendazole (ALB) measured by different diagnostic methods
in a head-to-head comparison to the recommended single Kato-Katz.
Methods
An ALB efficacy trial was performed in 3 different STH-endemic countries (Ethiopia, Lao
PDR and Tanzania), each with a different PC-history. During these trials, stool samples
were evaluated with Kato-Katz (single and duplicate), Mini-FLOTAC, FECPAKG2, and
qPCR. The reduction rate in mean eggs per gram of stool (ERR) and mean genome equiva-
lents / ml of DNA extract (GERR) were calculated to estimate drug efficacy.
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Principal findings and conclusions
The results of the efficacy trials showed that none of the evaluated diagnostic methods
could provide reduction rates that were equivalent to a single Kato-Katz for all STH. How-
ever, despite differences in clinical sensitivity and egg counts, they agreed in classifying effi-
cacy according to World Health Organization (WHO) guidelines. This demonstrates that
diagnostic methods for assessing drug efficacy should be validated with their intended-use
in mind and that other factors like user-friendliness and costs will likely be important factors
in driving the choice of diagnostics. In addition, ALB efficacy against STH infections was
lower in sites with a longer history of PC. Yet, further research is needed to identify factors
that contribute to this finding and to verify whether reduced efficacy can be associated with
mutations in the β-tubulin gene that have previously been linked to anthelmintic resistance.
Trial registration
ClinicalTrials.gov NCT03465488.
Author summary
During the last decade, the scale of deworming programs that aim to eliminate the mor-
bidity caused by intestinal worms has increased to a level that is unprecedented in history.
It is therefore of utmost importance to monitor any change in therapeutic efficacy that
may arise from emerging drug resistance. Currently, a variety of novel methods have been
described, but it remains unclear whether they can be used for monitoring drug efficacy.
We applied different diagnostic methods to measure the efficacy of a commonly adminis-
tered drug in deworming programs in 3 countries with different historical exposure to
deworming programs. Compared to the standard diagnostic method, all diagnostic meth-
ods revealed good agreement in classifying the therapeutic efficacy according to World
Health Organization guidelines, despite clear differences in diagnostic performance. We
also noticed that the drug efficacy was lower in countries where drug pressure has been
high. However, more research is necessary to identify factors that explain this variation in
drug efficacy, including but not limited to the frequency in mutations in genes that are
known to be linked with anthelmintic resistance.
Introduction
Infections with soil-transmitted helminths (STHs; Ascaris lumbricoides, Trichuris trichiura,
Necator americanus and Ancylostoma duodenale) are responsible for the highest burden
among all neglected tropical diseases. Recent global estimates indicate that in 2015, more than
1.6 billion people were infected with at least one of the four STH species [1], resulting in a
global burden of approximately 1.9 million disability-adjusted life years [2]. Preventive chemo-
therapy (PC) or the periodical administration of a single-oral dose of albendazole (ALB; 400
mg) or mebendazole (MEB; 500 mg) to preschool- (PSAC) and school-aged children (SAC) is
the main strategy to control the morbidity caused by STHs [3]. In 2017, global coverage of PC
in at-risk populations was nearly 70%, though the target is to reach 75% coverage by 2020, and
to eventually eliminate soil-transmitted helminthiasis as a public health problem [4–6]. The
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latter target is defined by reaching less than 1% moderate and heavy intensity infections in
SAC [5].
The downside of these increased control efforts is that resistance to anthelmintic drugs,
such as ALB and MEB, is likely to develop. Both drugs belong to the same drug class (benz-
imidazole (BZ) drugs) and share the same mode of action. Moreover, they are administered in
single doses that usually do not achieve 100% efficacy [7–10]. Should anthelmintic resistance
(AR) against these BZ drugs eventually emerge and spread, it will jeopardize PC-based control
of STH due to the few acceptable alternative treatment options [11, 12]. All this reinforces the
urgent need to promote accessibility of anthelmintic drugs with different modes of action,
alone or in combination, and a thoroughly designed surveillance system that detects any
changes in anthelmintic drug efficacy arising through the evolution of AR.
The World Health Organization advises to monitor drug efficacy in case treatment failure
is suspected or–regardless of suspected drug failure–when drugs have been administered in
PC-programs for at least four years [13]. To monitor the efficacy of anthelmintic drugs against
STHs, WHO currently recommends measuring the reduction in number of STH eggs excreted
in stool after drug administration (egg reduction rate, ERR) using either a single Kato-Katz
thick smear or the McMaster method [13].
Recently, novel methods have been introduced in the field of STH diagnostics, including
Mini-FLOTAC [14, 15], FECPAKG2 [16, 17] and the DNA-based diagnostic methods such as
quantitative PCR (qPCR) [18–20]. Each of these methods offers one or more advantages over
the recommended methods, pertaining to increased clinical sensitivity [15, 18, 21–23] and
specificity (qPCR is able to differentiate different helminths at the species level) [24–27], qual-
ity assurance (FECPAKG2 automatically stores images of each sample which can be consulted
at any time [17, 28]; qPCR includes internal controls within each run [29]), flexibility as to
when samples are examined (for both Mini-FLOTAC and qPCR, stool can be preserved for
analysis at a later time point [23, 25, 30–32]). Although each of these novel methods has
recently been used to evaluate drug efficacy [16, 33, 34], there remains a paucity of studies that
perform a head-to-head comparison of the drug efficacy obtained by different diagnostic
methods. Moreover, these studies tested the hypothesis that the methods provide significantly
different ERR estimates. Rather, the correct hypothesis is to assess whether these differences
are within the bounds of equivalence. As illustrated in supplementary information (S1 Info),
the absence of a significant difference does not imply equivalent ERR estimates nor does the
presence of a significant difference rule out equivalent ERR results.
Therefore, in this study we compared the equivalence in ALB efficacy measured by dupli-
cate Kato-Katz thick smear, Mini-FLOTAC, FECPAKG2 and qPCR in a head-to-head compar-
ison with a single Kato-Katz thick smear. For this, a drug efficacy trial with ALB was
performed in three different countries (Ethiopia, Lao PDR and Pemba (Tanzania)) with differ-
ent historical levels of drug exposure.
Methods
Ethics statement
The study protocol has been reviewed and approved by the Institutional Review Board (IRB)
of the Faculty of Medicine and Health Sciences of Ghent University, Belgium (Ref. No
B670201627755; 2016/0266). The trial protocol was subsequently reviewed and approved by
the IRBs associated with each trial site (Ethical Review Board of Jimma University, Jimma,
Ethiopia: RPGC/547/2016; National Ethics Committee for Health Research, Vientiane, Lao
PDR: 018/NECHR; Zanzibar Medical Research and Ethics Committee, United Republic of
Tanzania: ZAMREC/0002/February/2015 and the IRB from Centro de Pesquisas Rene´ Rachou,
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Belo Horizonte, Brazil: 2.037.205). The trial was retrospectively registered on Clinicaltrials.gov
(ID: NCT03465488) on March 7, 2018.
Parent(s)/guardians of participants signed an informed consent document indicating that
they understood the purpose and procedures of the study, and that they allowed their child to
participate. If the child was�5 years, he or she had to orally assent in order to participate. Par-
ticipants of�12 years of age were only included if they signed an informed consent document
indicating that they understood the purpose and the procedures of the study, and were willing
to participate.
Study design and population
The selection of the study sites was based on their experience in assessing drug efficacy, evalu-
ating the performance of diagnostic methods, the availability of well-equipped diagnostic facil-
ities and skilled personnel, and PC-history [35]. Based on the reported national coverage of
drug administration to both PSAC and SAC for the last 5 years (2009–2014; Preventive Che-
motherapy Database of the WHO), the site in Ethiopia was considered to have experienced a
low drug exposure, the site in Lao PDR a medium drug exposure and the site in Pemba (Tan-
zania) a high drug exposure prior to the start of the trials [35] (Table 1). Note that the initial
study protocol included a study site in Brazil. However, due to the low number of cases on
which not all diagnostic methods were performed, the site was excluded from this report.
The trials were designed to assess an equivalence in treatment efficacy of a single oral dose
of 400 mg ALB against STH infections in SAC measured by a variety of diagnostic methods.
The study focused on SAC (age 5–14) since they are the major target of PC programs, and they
usually represent the group with highest worm burdens for A. lumbricoides and T. trichiura
[36]. Subjects were not included in the study if they could not provide a stool sample at base-
line or follow-up and had active diarrhea or any other acute medical condition at baseline.
Children with a known hypersensitivity to ALB or MEB, who received anthelmintic treatment
within 90 days prior to the start of the trial were and did not swallow the entire drug tablet or
vomited within four hours following drug ingestion were also excluded from the study.
At the start of each trial, schools were visited by the local principal investigator and a team
of field officers, who explained the planned trial and sampling method to the parents and
teachers and the children. At baseline, SAC were asked to provide a fresh stool sample, after
which they were administered a single oral dose of 400 mg ALB under supervision. The ALB
used in the different studies originated from the same production batch (GlaxoSmithKline
Batch N˚: 335726) and was provided by WHO. All collected stool samples were kept in a cooler
with ice packs while transported to the laboratory, where they were processed on the same day
of collection. Stool samples were processed to determine the fecal egg counts (FECs; expressed
in eggs per gram of stool (EPG)) for each STH using Kato-Katz (single and duplicate), Mini-
FLOTAC and FECPAKG2. As FECs of the latter technique could not finalized on the day of
sample collection (see section Diagnostic methods), results of the FECPAKG2 technique were
Table 1. Location and treatment history of the four study sites.
Country District/Province/State Treatment history
Brazil Minas Gerais PC since 2007 (ALB)
Ethiopia Jimma PC since 2015 (ALB)
Lao PDR Nam Bak PC since 2007 (MEB)
Tanzania Pemba Island PC since 1994 (ALB)
PC: preventive chemotherapy, ALB: albendazole, MBZ: mebendazole.
https://doi.org/10.1371/journal.pntd.0007471.t001
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not used to select individuals for inclusion at follow-up. Aliquots of a subset of the baseline
samples were preserved in ethanol for molecular analysis. Preliminary data has indicated that
downstream analysis of STH β-tubulin genes was very challenging when egg concentration
was low (data not published). Therefore, only samples with a FEC of�150 EPG for at least one
STH species were withheld for further molecular analysis. Fourteen to 21 days after drug
administration, a second stool sample was collected from all the children that were found posi-
tive for any STH by duplicate Kato-Katz or Mini-FLOTAC at baseline. Stool samples collected
at follow-up were again examined by Kato-Katz (single and duplicate), Mini-FLOTAC and
FECPAKG2. Aliquots from all follow-up samples were preserved for further molecular analysis
regardless of the FECs.
Sample size calculation
A sample size was calculated to test the hypothesis that FECPAKG2, Mini-FLOTAC and dupli-
cate Kato-Katz provide equivalent drug efficacy results measured by ERRs compared to a sin-
gle Kato-Katz. This sample size calculation did not include the qPCR method. Given the
differences in drug efficacy of ALB across the STH species [8, 9] (A. lumbricoides: ~99%, hook-
worms: ~96%, T. trichiura: ~65%), a level of equivalence that is acceptable for T. trichiura may
not be acceptable for A. lumbricoides. We therefore applied a level of equivalence that was tai-
lored to the different STH species. The level of equivalence for A. lumbricoides, hookworms
and T. trichiura was set arbitrarily at -/+2.5, -/+5.0 and -/+10-point percentage respectively.
This means that a method provides equivalent drug efficacy estimates as single Kato-Katz if
the confidence intervals surrounding the mean difference in drug efficacy does not exceed
these set of values (S1 Info). To calculate the corresponding sample size for each of the STH
species, a simulation study was performed that considered (i) the variation in ERR and base-
line FECs both across and within STH species, (ii) the variation in FECs introduced by the egg
counting process, (iii) the paired ERR results across diagnostic methods, and (iv) a post-hoc
correction for a pair-wise comparison. Based on this simulation, at least 110, 100 and 12 com-
plete cases are required for T. trichiura, hookworm and A. lumbricoides, respectively. A
detailed description of the sample size calculation is available elsewhere [35].
Diagnostic methods
Upon arrival in the laboratory, stool samples were homogenized with a wooden spatula and
subsequently subjected to microscopic examination by means of single and duplicate Kato-
Katz, Mini-FLOTAC and FECPAKG2. Two aliquots of 0.5 g stool were also preserved in an
Eppendorf tube containing 1 ml of absolute ethanol for later DNA extraction and qPCR analy-
sis. Detailed standard operating procedures (SOPs) for the different diagnostic methods were
published earlier [35, 37]. Here we briefly mention the most important steps for each of the
methods.
For Kato-Katz, two slides were prepared (slide A and B) and examined for the presence of
STH eggs within 30–60 min following preparation. The results of slide A represented the
results of a single Kato-Katz and egg counts were multiplied by 24 to obtain the FECs
(expressed as EPG). The sum of the egg counts obtained after reading slide A and B repre-
sented the results for duplicate Kato-Katz and were multiplied by 12 to obtain the FECs.
For Mini-FLOTAC, we homogenized 2 g of fresh stool with 38 ml of flotation solution (sat-
urated salt solution, density = 1.20) in the Fill-FLOTAC recipient [15]. After transferring the
suspension into the two chambers of the Mini-FLOTAC device, the device was placed on a
horizontal surface for 10 min after which the reading disk was translated. Finally, both Mini-
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FLOTAC chambers were screened for the presence of STH eggs. The number of eggs counted
were multiplied by 10 to obtain the FECs.
The FECPAKG2 method was performed as described by Ayana et al. [17]. Briefly, stool was
homogenized in tap water in a Fill-FLOTAC device [15], after which it was transferred into a
FECPAKG2 sedimenter to allow STH eggs to sediment. The following day, the supernatant was
poured off and saturated saline solution (specific density = 1.2) was added to the remaining
slurry. The whole content of the sedimenter was then poured into a FECPAKG2 filtration unit
from which 2 separate aliquots were taken and transferred to 2 wells of a FECPAKG2 cassette.
Following an accumulation step of at least 20 minutes, the cassettes were placed in the Micro-I
device for image capture. The device automatically imaged both wells and stored the images
prior to uploading them to the FECPAKG2 server. Finally, the mark-up technician identified
and counted any STH eggs present in the images using specialized software. Mark-up of the
images was not performed on the day of examination and hence the results were not used to
select individuals for inclusion in follow-up. Results of the mark-up were saved automatically
for reporting and analysis. For FECPAKG2 the eggs counted in both wells were multiplied by
34 to calculate the FECs.
For quality control purposes, a predefined, randomly selected subset of samples (10% of the
total number of samples) was re-evaluated by each of the three egg count methods. To this
end, a senior researcher, who was blinded to the initial FECs, re-counted STH eggs across all
three egg count methods. A third examiner would re-count STH eggs in case of discrepancies.
An in-depth analysis of these quality control results will be published in a separate manuscript.
In order to perform qPCR, DNA was extracted from the preserved stool samples and ana-
lyzed for the presence of DNA of STH at the Laboratory for Medical Microbiology and Immu-
nology (Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands) as part of two multiplex
qPCR assays [35]. The variation between runs was monitored by means of the Cq values of the
positive controls (DNA template for each STH species). We defined the variation between
runs negligible when the difference in Cq values of the positive controls between runs did not
exceed 1. The inhibition of the qPCR assay was controlled by adding a known quantity of pho-
cine herpes virus DNA in each DNA extract and by subsequently quantifying this virus’ DNA
by qPCR. Inhibition was present in the sample when the difference in Cq-value between the
virus’ DNA in a clinical sample and a pure virus DNA sample did not exceed 1. We did not
observe a difference in Cq across controls of more than 1 Cq, nor did we observe inhibition of
the qPCRs in any of the samples (quality control results will be published in a follow-up manu-
script). For each target species, qPCR results were expressed as genomic equivalents per ml of
DNA extract (GE/ml). The reported qPCR results for hookworms were calculated as the sum
of GE/ml of both hookworm species (Ancylostoma and Necator americanus).
Statistical analysis
A sample was considered positive for a STH infection if it tested positive on at least one diag-
nostic method (duplicate Kato-Katz, Mini-FLOTAC, FECPAKG2 or qPCR). The efficacy of a
single oral dose of 400 mg ALB is reported separately for each STH species and for each micro-
scopic method by means of ERR, using the following formula: ERR (%) = 100% x [1- (arithme-
tic mean FEC at follow-up / arithmetic mean FEC at baseline)]. For qPCR, a similar formula
was used, where FEC was replaced by DNA concentration (GE/ml), yielding the genome
equivalent reduction rate (GERR): GERR (%) = 100% x [1- (arithmetic mean DNA concentra-
tion at follow-up / arithmetic mean DNA concentration at baseline)]. A bootstrap analysis was
used to determine the corresponding 95% confidence intervals (95%CI) around the (G)ERR
point estimate for each diagnostic method and the difference in drug efficacy compared to a
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single Kato-Katz across diagnostic methods. A permutation test was used to assess the equiva-
lence in (G)ERR between single Kato-Katz thick smear and either duplicate Kato-Katz, Mini-
FLOTAC, FECPAKG2 or qPCR. Bonferroni’s correction was applied for multiple comparison
between methods (level of significance was set at 0.0125 = 0.05 / 4 comparisons).
The (G)ERR point estimates were used to classify drug efficacy as ‘satisfactory’, ‘doubtful’
or ‘reduced’ following the WHO criteria recommended for a single Kato-Katz [13] (Table 2).
In addition, the agreement between a single Kato-Katz and the other methods in the assign-
ment of drug efficacy into ‘satisfactory’, ‘doubtful’ and ‘reduced’ was evaluated by Fleiss’ kappa
statistic (κFleiss). The value of this statistic indicates a slight (κFleiss <0.2), fair (0.2� κFleiss
<0.4), moderate (0.4� κFleiss <0.6), substantial (0.6� κFleiss,<0.8) or an almost perfect agree-
ment (κFleiss�0.8).
Finally, we also assessed the distribution of individual responses measured across the five
diagnostic methods. Individual ERR (iERR) were calculated using the following formula:
iERR = 100% x [1- (FEC at follow-up of individual i / FEC at baseline of individual i)]. Individ-
ual GERR (iGERR) were calculated using the following formula: iGERR = 100% x [1- (DNA
concentration at follow-up of individual i / DNA concentration at baseline of individual i)].
We classified the individual response for each STH species and for each method into ‘cured’
(no eggs/DNA was found in follow-up sample), ‘satisfactory’, ‘doubtful’ or ‘reduced’ (see
Table 1) and ‘absent’ (drug efficacy was below zero due to higher egg counts or DNA-concen-
tration in the follow-up sample than in baseline sample). Subsequently, the agreement between
a single Kato-Katz and the other methods in the assignment of individual drug efficacy was
assessed by Fleiss’ kappa statistic (κFleiss). All statistical analyses were performed in R [38].
Graphs were produced using R.
Results
Demographics and STH status of the complete cases
The number of children that were withheld after recruitment and at baseline or follow-up vis-
its, and those that were eventually incorporated in the final statistical analysis are summarized
in Fig 1. Complete data was available for 645 children across three of the four study sites (Ethi-
opia: 161 cases; Lao PDR: 239 cases; Pemba (Tanzania): 245 cases).
With the exception of Pemba (Tanzania), where more females (n = 137) were included than
males (n = 108), the sex ratio (males:females) was approximately 1:1 in all study sites. The
median age (25th and 75th quantile) of the children across the three study sites equaled 11.0
years (9.0; 12.0). The participants in Ethiopia (9.0 years [8.0; 10.0]) were slightly younger than
those in Lao PDR (12.0 years [11.0; 13.0]) and Pemba (Tanzania; 11.0 years [10.0; 12.0]). In
total, there were 441 complete cases for A. lumbricoides (Ethiopia: 137, Lao PDR: 111, Pemba
(Tanzania): 193), 456 for T. trichiura (Ethiopia: 106, Lao PDR: 105, Pemba (Tanzania): 245)
and 457 for hookworm (Ethiopia: 90, Lao PDR: 228, Pemba (Tanzania): 139). The qPCR
results showed that all individuals who excreted hookworm eggs were infected with N. ameri-
canus. Both N. americanus and Ancylostoma DNA was detected in only 8 individuals from one
Table 2. Classification of the efficacy of a single oral dose 400 mg albendazole against soil-transmitted helminths. The efficacy is measured as the reduction in mean
fecal egg counts following drug administration (ERR). These thresholds were recommended by the World Health Organization for a single Kato-Katz.
Helminth species Satisfactory Doubtful Reduced
Ascaris lumbricoides �95% 85%� ERR <95% <85%
Trichuris trichiura �50% 40%� ERR <50% <40%
Hookworm �90% 80%� ERR <90% <80%
https://doi.org/10.1371/journal.pntd.0007471.t002
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Fig 1. Number of subjects withheld at recruitment, baseline and follow-up, and for statistical data analysis. FECs: fecal egg
counts expressed in eggs per gram of stool (EPG), 2x KK: duplicate Kato-Katz.
https://doi.org/10.1371/journal.pntd.0007471.g001
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school in Pemba (Tanzania). The qPCR results for hookworm used in our calculations repre-
sent the combined GE/ml detected for both species. Due to the nature of the school selection
procedure (prioritization of schools where STH prevalence was expected to be moderate to
high and premature discontinuation of recruitment in a school when the prevalence of STH
was low), the number of complete cases is not equally distributed across the schools. A minor-
ity of the schools actually provide the majority of the infected children (S2 Info).
Equivalence in therapeutic drug efficacy
Tables 3–5 describe the efficacy of ALB measured by the different diagnostic methods across
the three study sites for A. lumbricoides, T. trichiura and hookworm, respectively. For A. lum-
bricoides infections, efficacy of a single-oral dose of 400 mg ALB estimated by single Kato-Katz
was high (ERR>95%) across the different study sites (Table 3). This high drug efficacy was
confirmed by the three microscopic methods as well as by qPCR. The absolute point percent
difference in drug efficacy did not exceed 2% (duplicate Kato-Katz: 0–0.1%; Mini-FLOTAC:
0.1%– 0.6%; FECPAKG2: 0.0%– 1.8%; qPCR: 0.0%– 0.8%). All diagnostic methods provided
significantly equivalent estimates of drug efficacy compared to a single Kato-Katz (i.e. the 95%
CI around the difference in drug efficacy between diagnostic methods did not include 2.5%),
except for FECPAKG2 in Pemba (Tanzania) and qPCR in both Ethiopia and Pemba (Tanza-
nia), where evidence of equivalent drug efficacy was marginal since CIs included the 2.5%
Table 3. Equivalence of ALB drug efficacy against Ascaris lumbricoides measured by five diagnostic methods. Mean intensity of infection corresponds with the mean
fecal egg counts (FEC; expressed as eggs per gram of stool (EPG)) for single (1x KK) and duplicate (2x KK) Kato-Katz, Mini-FLOTAC and FECPAKG2 and with the mean
DNA concentration (expressed as genome equivalents per ml of DNA (GE/ml)) for qPCR. For A. lumbricoides, there is significant evidence that a diagnostic method
results in equivalent drug efficacy results compared to a 1x KK when the 95% confidence intervals (95%CI) around the difference in drug efficacy does not include
+/-2.5%. Significant evidence of equal drug efficacy results is indicated by ‘�’. For A. lumbricoides, drug efficacy was classified as ‘satisfactory’ when drug efficacy�95%,
reduced when drug efficacy was less than 85% or doubtful in all other cases.
A. lumbricoides Mean intensity of
infection at baseline
Mean intensity of infection
at follow-up
Drug efficacy
(%)
[95%CI]
Difference in drug efficacy compared
to 1x KK [95%CI]
Drug efficacy based on
WHO thresholds
Ethiopia (n = 137)
1x KK 7,869.5 6.0 99.9 [99.8; 100] - Satisfactory
2x KK 7,937.6 5.6 99.9 [99.8; 100] 0.0 [0.0; 0.0]� Satisfactory
Mini-
FLOTAC
4,408.4 7.4 99.8 [99.6; 100] 0.1 [0.0; 0.3]� Satisfactory
FECPAKG2 1,622.3 2.7 99.8 [99.5; 100] 0.1 [-0.1; 0.4]� Satisfactory
qPCR 15,466.0 145.8 99.1 [96.7; 100] 0.8 [-0.1; 4.3] Satisfactory
Lao PDR (n = 111)
1x KK 13,028.5 105.9 99.2 [97.7; 100] - Satisfactory
2x KK 13,045.2 104.6 99.2 [97.8; 99.9] 0.0 [-0.1; 0.0]� Satisfactory
Mini-
FLOTAC
5,592.9 66.4 98.8 [97.5; 100] 0.6 [-0.2; 1.6]� Satisfactory
FECPAKG2 2,711.1 23.0 99.2 [97.0; 99.9] 0.0 [-1.0; 1.2]� Satisfactory
qPCR 16,210.5 150.6 99.1 [97.6; 99.8] 0.1 [-1.2; 1.5]� Satisfactory
Pemba (Tanzania) (n = 193)
1x KK 14,371.8 458.5 96.8 [92.1; 99.5] - Satisfactory
2x KK 15,075.0 504.2 96.7 [91.5; 99.6] 0.1 [-0.2; 1.0]� Satisfactory
Mini-
FLOTAC
11,135.5 369.0 96.7 [96.5; 99.8] 0.1 [-1.4; 1.4]� Satisfactory
FECPAKG2 6,322.1 90.0 98.6 [92.5; 99.4] -1.8 [-5.7; 0.8] Satisfactory
qPCR 54,790.6 1,735.9 96.8 [93.1; 99.3] 0.0 [-6.5; 5.5] Satisfactory
https://doi.org/10.1371/journal.pntd.0007471.t003
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bounds of equivalence (FECPAKG2: [-5.7%; 0.8%]; qPCR: [-6.5%; 5.5%] in Pemba (Tanzania)
and [-0.1%; 4.3%] in Ethiopia).
For T. trichiura infections, ALB efficacy estimations varied significantly depending on the
study site and the diagnostic method that was used (Table 4). Estimations obtained by single
Kato-Katz were 52.9% in Ethiopia, 36.7% in Lao PDR and -11.2% in Pemba (Tanzania). There
was a large deviation from the drug efficacy measured by single Kato-Katz and those based on
the other diagnostic methods. The absolute point percent difference between single Kato-Katz
and the other methods was the smallest for duplicate Kato-Katz (4.8%– 6.3%) and the largest
for qPCR (14.6%– 60.2%). None of the methods provided equal drug efficacy results (CI
around the difference in drug efficacy between diagnostic methods included the 10% bounds
of equivalence). Moreover, clear difference could be noted across the different methods. In
contrast to the other methods, drug efficacy measured by a duplicate Kato-Katz was marginally
equivalent to those obtained by single Kato-Katz with the CI just including the 10-point per-
cent (Ethiopia: [-0.6%; 10.4%]; Lao PDR: [-12.0%; 3.1%] and Pemba (Tanzania): [-14.9%;
1.9%]).
For hookworm infections (Table 5), the drug efficacy measured by single Kato-Katz was
high (>95%) in both Ethiopia (96.3%) and Lao PDR (96.1%), but moderate in Pemba (Tanza-
nia) (84.2%). Overall, these drug efficacy estimates were confirmed by the other diagnostic
methods. The absolute point percent differences in drug efficacy did not exceed 7% (duplicate
Kato-Katz: 0%– 0.6%; Mini-FLOTAC: 0.9%– 2.7%; FECPAKG2: 1.3%– 6.1%; qPCR: 1.5%–
Table 4. Equivalence of drug efficacy of albendazole against Trichuris trichiura measured by five diagnostic methods. Mean intensity of infection corresponds with
the mean fecal egg counts (FEC; expressed as eggs per gram of stool (EPG)) for single (1x KK) and duplicate (2x KK) Kato-Katz, Mini-FLOTAC and FECPAKG2 and with
the mean DNA concentration (expressed as genome equivalents per ml of DNA (GE/ml)) for qPCR. For T. trichiura, there is significant evidence that a diagnostic method
results in equivalent drug efficacy results compared to a 1x KK when the 95% confidence intervals (95%CI) around the difference in drug efficacy does not include +/-10%.
Significant evidence of equal drug efficacy results is indicated by ‘�’. For T. trichiura, drug efficacy was classified as ‘satisfactory’ when drug efficacy�50%, reduced when
drug efficacy was less than 40% or doubtful in all other cases.
T. trichiura Mean intensity of
infection at baseline
Mean intensity of
infection at follow-up
Drug efficacy
(%)
[95%CI]
Difference in drug efficacy
compared to 1x KK [95%CI]
Drug efficacy based on
WHO thresholds
Ethiopia (n = 106)
1x KK 206.7 97.4 52.9 [39.1; 65.7] - Satisfactory
2x KK 195.2 101.3 48.1 [33.2; 62.7] 4.8 [-0.6; 10.4] Doubtful
Mini-
FLOTAC
147.0 93.3 36.5 [14.9; 56.2] 16.4 [-1.0; 36.4] Reduced
FECPAKG2 15.1 12.2 19.1 [-27.8; 55.8] 33.8 [-8.5; 101.0] Reduced
qPCR 770.4 250.5 67.5 [27.5; 83.8] 14.6 [-39.5; 39.3] Satisfactory
Lao PDR (n = 105)
1x KK 356.8 225.8 36.7 [-0.6; 57.8] - Reduced
2x KK 359.1 213.7 40.5 [4.4; 61.0] 3.8 [-12.0; 3.1] Doubtful
Mini-
FLOTAC
228.5 119.0 47.9 [23.9; 64.3] 11.2 [-49.8; 13.9] Doubtful
FECPAKG2 48.6 41.4 14.7 [-54.1; 47.0] 22.0 [-41.2; 126.4] Reduced
qPCR 628.7 656.5 -4.4 [-78.9; 41.7] 41.1 [-32.7; 152.6] Reduced
Pemba (Tanzania) (n = 245)
1x KK 3,110.5 3,459.1 -11.2 [-30.4; 5.9] - Reduced
2x KK 3,384.0 3,549.2 -4.9 [-23.8; 12.0] 6.3 [-14.9; 1.9] Reduced
Mini-
FLOTAC
3,463.5 2,949.3 14.8 [-0.6; 28.8] 26.0 [-45.2; -9.2] Reduced
FECPAKG2 495.6 488.9 1.3 [-24.7; 21.3] 12.5 [-43.2; 21.7] Reduced
qPCR 12,657.9 6,461.5 49.0 [4.5; 73.3] 60.2 [-99.8; -2.0] Doubtful
https://doi.org/10.1371/journal.pntd.0007471.t004
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4.6%). A duplicate Kato-Katz provided equivalent drug efficacy estimates across all study sites
(the CI around the difference in drug efficacy between diagnostic methods did not include the
5% bounds of equivalence, Ethiopia: [95%CI: -0.5; 0.9], Lao PDR: [95%CI: -0.6; 0.2]); Pemba
(Tanzania) [95%CI: -1.5; 3.2]). The only other significant equivalent drug efficacy result was
found for FECPAKG2 in Lao PDR (95%CI: -3.7; 0.9). The remaining pair-wise comparisons in
both Ethiopia (Mini-FLOTAC: [95%CI: -2.1; 9.0]; FECPAKG2: [95%CI: -8.1; 0.9]; qPCR: [95%
CI: -2.4; 7.6]) and Lao PDR (Mini-FLOTAC: [95%CI: -0.6; 6.0%]; qPCR: [95%CI: -2.1; 7.7])
indicated that drug efficacies were marginally equivalent, the 95%CI just including the 5%
equivalence threshold. This was in contrast to the findings from Pemba (Tanzania) where no
clear evidence of equivalent drug efficacies for Mini-FLOTAC [95%CI: -11.8; 9.0%], FEC-
PAKG2 [95%CI: -15.9; 3.0] and qPCR [95%CI: -10.8; 31.4] was observed.
In summary, a duplicate Kato-Katz provided drug efficacy significantly or marginally
equivalent to a single Kato-Katz for the three STH species in all study sites. For the other meth-
ods, the equivalence of drug efficacy varied by STH species and study site.
Agreement in classifying drug efficacy
Table 6 summarizes the agreement in classifying the efficacy of ALB between single Kato-Katz
and the other diagnostic methods across the three study sites for each STH species. For both
duplicate Kato-Katz (κFleiss = 0.81, p<0.001) and qPCR (κFleiss = 0.84, p<0.001) there was
Table 5. Equivalence of drug efficacy of albendazole against hookworm infections measured by five diagnostic methods. Mean intensity of infection corresponds
with the mean fecal egg counts (FEC; expressed as eggs per gram of stool (EPG)) for a single (1x KK) and duplicate (2x KK) Kato-Katz, Mini-FLOTAC and FECPAKG2
and with the mean DNA concentration (expressed as genome equivalents per ml of DNA (GE/ml)) for qPCR. For hookworm, there is significant evidence that a diagnostic
method results in equivalent drug efficacy results compared to a 1x KK when the 95% confidence intervals (95%CI) around the difference in drug efficacy does not include
+/- 5%. Significant evidence of equal drug efficacy results is indicated by ‘�’. For hookworm, drug efficacy was classified as ‘satisfactory’ when drug efficacy�90%, reduced
when drug efficacy was less than 80% or doubtful in all other cases.
Hookworm Mean intensity of
infection at baseline
Mean intensity of
infection at follow-up
Drug efficacy
(%)
[95%CI]
Difference of drug efficacy
compared to 2x KK [95%CI]
Drug efficacy based on
WHO thresholds
Ethiopia (n = 90)
1x KK 247.7 9.1 96.3 [92.8; 98.5] - Satisfactory
2x KK 242.1 9.1 96.3 [92.7; 98.3] 0.0 [-0.5; 0.9]� Satisfactory
Mini-
FLOTAC
153.2 9.8 93.6 [87.9; 97.1] 2.7 [-2.1; 9.0] Satisfactory
FECPAKG2 103.5 0.8 99.3 [97.3; 100] 3.0 [-8.2; 0.9] Satisfactory
qPCR 20,653.4 1,150.1 94.4 [88.8; 97.7] 1.9 [-2.4; 7.6] Satisfactory
Lao PDR (n = 228)
1x KK 2,079.1 81.8 96.1 [93.7; 97.7] - Satisfactory
2x KK 2,043.8 76.9 96.2 [94.0; 97.8] -0.1 [-0.6; 0.2]� Satisfactory
Mini-
FLOTAC
820.0 46.7 94.3 [90.6; 96.8] 1.8 [-0.6; 6.0] Satisfactory
FECPAKG2 657.8 17.0 97.4 [95.6; 98.7] -1.3 [-3.7; 0.9]� Satisfactory
qPCR 273,720.7 14,827.6 94.6 [89.2; 97.6] 1.5 [-2.1; 7.7] Satisfactory
Pemba (Tanzania) (n = 139)
1x KK 285.4 45.2 84.2 [75.4; 90.7] - Doubtful
2x KK 286.9 47.1 83.6 [74.4; 90.3] 0.6 [-1.5; 3.2]� Doubtful
Mini-
FLOTAC
215.5 32.0 85.1 [74.7; 91.8] -0.9 [-11.8; 9.0] Doubtful
FECPAKG2 141.9 13.7 90.3 [81.4; 95.7] -6.1 [-15.9; 3.0] Satisfactory
qPCR 127,139.3 25,941.6 79.6 [58.7; 92.6] 4.6 [-10.8; 31.4] Reduced
https://doi.org/10.1371/journal.pntd.0007471.t005
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almost a perfect agreement (κFleiss�0.8). Both these methods agreed with a single Kato-Katz
in 7 out of the 9 observations. For FECPAKG2 (κFleiss = 0.65, p = 0.01) there was a substantial
agreement (0.61� κFleiss <0.81), for MiniFLOTAC (κFleiss = 0.60, p = 0.03) there was a moder-
ate agreement (0.41� κFleiss <0.61).
Individual drug responses
Figs 2–4 provide an overview of individual drug responses to ALB for the five diagnostic meth-
ods across the different sites for A. lumbricoides, T. trichiura and hookworm, respectively. The
top three bar plots illustrate the different classifications of individual drug efficacy for that hel-
minth species detected in the study population in each of the three countries by five different
diagnostic methods. Based on their i(G)ERR, individuals are classified into one of seven differ-
ent categories, which in turn correspond with a specific color, ranging from dark green
(completely cured, i(G)ERR = 100%) to dark red (eggs/DNA detected at follow-up but not at
baseline, i(G)ERR = -1). The grey part of the bar represents the individuals for whom no effi-
cacy could be calculated since no eggs or DNA was detected for that species at baseline and fol-
low-up. The bottom three bar plots represent the individual drug efficacy for those 770
individuals for whom i(G)ERR was measured with each of the five diagnostic methods.
Generally, these figures highlight three important findings. First, they confirm the distinct
differences in sensitivity across the diagnostic methods. FECPAKG2 was previously evaluated
as being less sensitive than Kato-Katz, while qPCR was found to have superior sensitivity for
all STH [16, 26, 39]. This is also supported by the results of our study, where we noticed high
numbers of false negative test results at baseline and follow-up for FECPAKG2. When applying
FECPAKG2, drug efficacy could not be measured in 438 (32.3%) of the 1,354 individuals with
STH infection, because of false negative results at baseline (A. lumbricoides: 148/441, T. tri-
chiura: 135/456 and hookworms: 155/457). In contrast, when applying qPCR, individual drug
efficacy could not be measured in only 56 (4.1%) of the 1,354 individuals because of false
Table 6. Agreement in classifying the efficacy of albendazole between single Kato-Katz and duplicate Kato-Katz, Mini-FLOTAC, FECPAKG2 and qPCR. The cross
tables represent the agreement in classifying the efficacy of albendazole as ‘satisfactory’, ‘doubtful’ or ‘reduced’, between a single Kato-Katz (1x KK) and a duplicate Kato-
Katz (2x KK), Mini-FLOTAC, FECPAKG2 and qPCR across the three study sites and for each soil-transmitted helminth species (9 observations). Drug efficacy is based on
egg reduction rate (ERR) for microscopic methods and by means of reduction in genome equivalents (GERR) for qPCR. World Health Organization criteria to define
drug efficacy into ‘satisfactory’, ‘doubtful’ and ‘reduced’ were previously recommended for a single Kato Katz (see Table 2).
1x KK κFleiss, p-value
Satisfactory Doubtful Reduced
2x KK Satisfactory 5 0 0 0.81, p <0.001
Doubtful 1 1 1
Reduced 0 0 1
Satisfactory Doubtful Reduced
Mini-FLOTAC Satisfactory 5 0 0 0.60, p = 0.03
Doubtful 0 1 1
Reduced 1 0 1
Satisfactory Doubtful Reduced
FECPAKG2 Satisfactory 5 1 0 0.65, p = 0.01
Doubtful 0 0 0
Reduced 1 0 2
Satisfactory Doubtful Reduced
qPCR Satisfactory 6 0 0 0.84, p<0.001
Doubtful 0 0 1
Reduced 0 1 1
https://doi.org/10.1371/journal.pntd.0007471.t006
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negative results at baseline (top graphs of Figs 2–4: A. lumbricoides: 22/441, T. trichiura: 11/
456 and hookworm: 23/456).
Second, they indicate that there are a number of cases where eggs or DNA were found at
follow-up, but not at baseline (this mathematically results in an infinite increase of eggs or
DNA at follow-up or an individual drug efficacy of minus infinity (dark red portion of bars in
upper panels). Overall, these types of cases were observed by at least one diagnostic method in
8% of the total number of cases (n = 1,354), but differences across diagnostic methods and
STH were observed. They were more prevalent when the FECPAKG2 method was used (5.5%
= 75/1,354). For the other diagnostic methods, the proportion of samples that were positive at
follow-up but negative at baseline did not exceed 1.3% (single Kato-Katz: 1.2%; duplicate
Kato-Katz: 1.3%; Mini-FLOTAC: 1.0%; qPCR: 1.2%), the majority being T. trichiura cases
(17.2% = 78/456). The cases were less frequently observed for hookworm (5.3% = 24/457) and
A. lumbricoides (1.8% = 8/441).
Fig 2. The individual drug efficacy of albendazole against Ascaris lumbricoides, measured by five diagnostic
methods. The upper three bar plots illustrate the different classifications of individual albendazole efficacy for A.
lumbricoides detected in the study population (n = 441; Ethiopia: 137, Lao PDR: 111, Pemba (Tanzania): 193) in each
of the 3 countries using 5 different diagnostic methods (single (1x KK) and duplicate Kato-Katz (2x KK), Mini-
FLOTAC (MF), FECPAKG2 (FP) and qPCR). The bars represent the number of cases. The color of the bars reflects the
individual egg or genome equivalent reduction rate (i(G)ERR). The bottom three bar plots represent the classification
of the i(G)ERRs for A. lumbricoides for those individuals for which i(G)ERR data was available for all five diagnostic
methods (n = 258; Ethiopia: 80, Lao PDR: 50, Pemba (Tanzania): 128).
https://doi.org/10.1371/journal.pntd.0007471.g002
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Third, they indicate that variation in individual drug response across STH and countries is
similar across diagnostic methods. This is most obvious when we focus on the cases for which
an individual drug efficacy response was available for all methods (bottom panels of Figs 2–4).
When employing a single Kato-Katz, the highest drug efficacy was observed for A. lumbri-
coides followed by hookworms and T. trichiura. For A. lumbricoides, 96.9% (= 250/258) of the
individuals showed a drug response that was at least satisfactory (light green + dark green).
For hookworm, this proportion equaled 79.7% (= 204/256), whereas for T. trichiura this was
only 34.4% (= 88/256).
For A. lumbricoides, the proportions of individuals with at least satisfactory drug efficacy
(light green + dark green) as measured by single Kato-Katz were comparable across the 3
countries (Ethiopia: 100% (= 80/80); Lao PDR: 94.0% (= 47/50) and Pemba (Tanzania): 96.1%
(= 123/128)) (bottom graphs of Figs 2–4). For T. trichiura, fewer individuals showed satisfac-
tory drug efficacy to ALB in Pemba (Tanzania) compared to Lao PDR or Ethiopia (Pemba
Fig 3. The individual drug efficacy of albendazole against Trichuris trichiura, measured by five diagnostic
methods. The upper three bar plots illustrate the different classifications of individual albendazole efficacy for T.
trichiura detected in the study population (n = 456; Ethiopia: 106, Lao PDR: 105, Pemba (Tanzania): 245) in each of the
3 countries using 5 different diagnostic methods (single (1x KK) and duplicate Kato-Katz (2x KK), Mini-FLOTAC
(MF), FECPAKG2 (FP) and qPCR). The bars represent the number of cases. The color of the bars reflects the individual
egg or genome equivalent reduction rate (i(G)ERR). The bottom three bar plots represent the classification of the i(G)
ERRs for T. trichiura for those individuals for which i(G)ERR data was available for all five diagnostic methods
(n = 256; Ethiopia: 21, Lao PDR: 29, Pemba (Tanzania): 206).
https://doi.org/10.1371/journal.pntd.0007471.g003
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(Tanzania): 28.6% (= 59/206) vs. Lao PDR: 51.7% (= 15/29) or Ethiopia: 66.7% (= 14/21)).
When investigating the individual ALB response to hookworm, fewer individuals show satis-
factory drug efficacy in Pemba (Tanzania) (66.1% (= 37/56)) compared to Lao PDR (82.5% (=
137/166)) or Ethiopia (88.2% (= 30/34)). Regardless of the diagnostic method used, the same
trends in individual efficacy were apparent across STH species and countries.
Cross tables were made to gain more insights into the agreement between individual drug
response across the different methods (S3 Info). These tables illustrate the agreement of calcu-
lated i(G)ERR using single Kato-Katz and the four other methods for A. lumbricoides, T. tri-
chiura and hookworms, respectively. For a duplicate Kato-Katz an almost perfect agreement
(κFleiss� 0.80) was observed for each of the STH (A. lumbricoides: 0.96 T. trichiura: 0.91; hook-
worm: 0.96, p<0.001). For Mini-FLOTAC, there was an almost perfect agreement for A. lum-
bricoides (κFleiss = 0.88, p<0.001) and a substantial agreement for the other two STH (T.
Fig 4. The individual drug efficacy of albendazole against hookworm, measured by five diagnostic methods. The
upper three bar plots illustrate the different classifications of individual ALB efficacy for hookworm detected in the
study population (n = 457; Ethiopia: 90, Lao PDR: 228, Pemba, Tanzania: 139) in each of the 3 countries using 5
different diagnostic methods (single (1x KK) and duplicate Kato-Katz (2x KK), Mini-FLOTAC (MF), FECPAKG2 (FP)
and qPCR). The bars represent the number of cases. The color of the bars reflects the individual egg or genome
equivalent reduction rate (i(G)ERR). The bottom three bar plots represent the classification of the i(G)ERRs for
hookworm for those individuals for which i(G)ERR data was available for all five diagnostic methods (n = 256;
Ethiopia: 34, Lao PDR: 166, Pemba, Tanzania: 56).
https://doi.org/10.1371/journal.pntd.0007471.g004
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trichiura: 0.62; hookworm: 0.79, p<0.001). For FECPAKG2, there was moderate agreement for
A. lumbricoides (κFleiss = 0.55, p<0.001) and a fair agreement for the remaining STH (T. tri-
chiura: 0.31; hookworm: 0.39, p<0.001). For qPCR, there was a substantial agreement for
hookworms (κFleiss = 0.61, p< 0.001), moderate agreement for both A. lumbricoides (κFleiss =
0.59, p<0.001), and a fair agreement for T. trichiura (κFleiss = 0.36, p<0.001).
Discussion
The present study evaluated the efficacy of ALB against STH infections in three different
endemic study sites using five different diagnostic methods. The rationale for this study was
twofold. First, we wanted to evaluate if the different diagnostic methods provide equivalent
drug efficacy results compared to a single Kato-Katz (the WHO recommended method) and
to ultimately make recommendations on which diagnostic methods can be used for assessing
drug efficacy. The second goal was to evaluate the ALB efficacy against STH in all three study
sites with varying anthelmintic drug pressure histories. The presented study is unique in a
number of ways. It is the first study that performs a multi-country, standardized, head-to-head
comparison of established (single and duplicate Kato-Katz) and novel microscopic (Mini-
FLOTAC and FECPAKG2) and molecular (qPCR) diagnostic methods for assessing drug effi-
cacy against STHs. This study was not designed to prove that ERR estimates differ across
methods, rather it verified whether methods are equivalent in assessing drug efficacy, which,
as illustrated in S1 Info, is a subtle, but important difference.
No single diagnostic method provides ERR that are equivalent to single
Kato-Katz for all STH, but they agree in classifying drug efficacy according
to the WHO guidelines
We found that none of the evaluated tests provided equivalent results to those obtained by sin-
gle Kato-Katz for all three STH. However, this conclusion needs to be interpreted with some
caution. First, the species-specific levels of equivalence (the predefined bounds of equivalence)
are arbitrary and likely to be set too strict. For instance, setting the level of equivalence at 10%
for T. trichiura might be too strict for Pemba (Tanzania) given that ALB efficacy measured by
duplicate Kato-Katz was -11.2%. On the other hand, the sample size was initially determined
to compare the microscopic methods only (See [35]). By adding the qPCR results to this com-
parison, we increased the number of comparisons from 3 to 4. Consequentially, the level at
which significant equivalence could be shown was reduced (0.05/4 = 0.0125 instead of 0.05/
3 = 0.0166). Moreover, the sample size calculation was performed bases on certain assump-
tions regarding the ERR and FECs across and within STH species, which might have resulted
in an underestimation of the true variation in the population [40, 41]. However, despite the
lack of equivalence, for most methods there was relatively good agreement in classifying ALB
efficacy according to WHO guidelines. This suggests that each method holds promise for the
assessment of drug efficacy in the context of assessing drug efficacy within STH control
programs.
Diagnostic methods for assessing drug efficacy need to be validated for
their intended-use
The results of the present study highlight that the impact of the diagnostic sensitivity on ERR
results is minimal (Tables 3–5 and Figs 2–4). Although there were substantial differences in
FECs across the different microscopic methods, this did not have a major impact on the equiv-
alence of ERR. For example, the FECs for A. lumbricoides based on single Kato-Katz were at
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least double of those based on FECPAKG2 across all study sites (Ethiopia: 7,870 EPG vs. 1,622
EPG; Lao PDR: 13,029 EPG vs. 2,711 EPG; Pemba (Tanzania): 14,372 EPG vs. 6,322 EPG), yet
at each study site both methods agreed that the efficacy is still satisfactory. This agreement in
drug efficacy, despite the clear differences in diagnostic sensitivity and FECs, are in line with
previous studies involving both animal [42] and human helminths [43–45], and underscore
that diagnostic methods need to be to be validated for their intended-use. Moreover, it high-
lights that other aspects such as user-friendliness and operational costs might become pivotal
factors when deciding to recommend or use any given method. Additionally, it should be
noted that our findings for qPCR do not necessarily apply for other qPCR assays, given that
the plethora of described qPCR assays for STHs can differ substantially in performance. It is
also important to point out that these findings are based on results obtained in sites where
STH prevalence and intensities of STH infections are still relatively high. It is possible that the
impact of the diagnostic sensitivity of a method on ERR calculations, as illustrated in animals,
will increase when working in settings with very low infection intensities [46, 47]
The efficacy of single ALB against was lower in sites where drug pressure
has been high
We strategically selected the different study sites to cover a wide range of drug pressure. In our
study, the study site in Ethiopia was least exposed to BZ drugs, followed by the one in Lao
PDR. On Pemba (Tanzania), BZ drugs had been most frequently administered. When focusing
on the drug efficacy estimated by single Kato-Katz, there was an obvious trend between the
drug pressure and drug efficacy for each of the three STH species. The ERRs dropped as a
function of historic drug pressure. The declining trend was most pronounced for T. trichiura,
for which ERR ranged from 52.9% in Ethiopia over 36.7% in Lao PDR to -11.2% in Pemba
(Tanzania). For both A. lumbricoides and hookworm, the efficacy of ALB was highest in both
Ethiopia and Lao PDR (A. lumbricoides: ~ 99% and hookworms: ~96%), and lowest on Pemba,
Tanzania (A. lumbricoides: 96.8%; hookworms: 84.2%). Whether this reduced drug efficacy on
Pemba (Tanzania) is indicative for the emergence of AR remains to be verified since it has
been shown that other factors may contribute to a reduced efficacy. For example, it has been
described that the efficacy of ALB against T. trichiura infections declines as a function of
increasing infection intensity [48]. This also seems to be the case in the present study, where
we notice a trend between average infection intensity (Pemba (Tanzania): 3,111 EPG; Lao
PDR: 357 EPG; Ethiopia: 207 EPG) and reduced drug efficacy (Pemba (Tanzania): -11.2%
ERR; Lao PDR: 36.7% ERR; Ethiopia: 52.9% ERR by single Kato-Katz). It is also possible that
both these processes occur simultaneously and mutually enhance the noticed effects of reduced
drug efficacy. Poor drug efficacy could result in increasing transmission and more subjects
being infected with a large number of worms.
To further assess the emergence of AR, we will analyze the frequency of known single
nucleotide polymorphisms (SNPs) in the β-tubulin gene at codons 167 (TTC to TAC), 198
(GAA to GCA) and 200 (TTC to TAC) in a subset of the baseline and follow-up samples [35].
Subsequently, individual-based drug efficacy models will be built to explore the association
between the frequency of these SNPs and other factors, including, but not limited to, infection
intensity [49]. The results of this analysis will be presented and discussed in detail in a follow-
up paper. At present, only a few studies with small sample sizes originating from a limited
number of endemic areas have been performed to assess the association between β-tubulin
SNPs and reduced anthelmintic efficacy in human STH [33, 50–55]. In these studies, it was
noted that polymorphisms were predominantly found in codon 200 of the β-tubulin gene and
that these mutations were more abundant in a T. trichiura worm population following drug
Efficacy of albendazole evaluated by five diagnostic methods
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administration. Nevertheless, no association could ever be proven with reduced drug efficacy
in any STH species. Overall, there are limited reports of declining or poor drug efficacy [9, 33,
56, 57]. Of note, some of these studies were flawed in terms of their design or analysis. For
example, Kru¨cken and colleagues reported a poor efficacy of ALB against A. lumbricoides
infections in Rwandan SAC, but the study findings might have been negatively affected by the
fact that follow-up sampling occurred too soon after drug administration (7–10 days), which
likely led to the detection of eggs from dying or degenerating worms [58].
Differential susceptibility of hookworm species to ALB
Interestingly, Pemba was the only site where both hookworm species were detected by qPCR.
In eight children, mixed infections with Ancylostoma spp. and N. americanus were identified,
confirming the finding by Albonico et al. [59]. Follow-up samples of these eight individuals
were all negative for Ancylostoma spp. (cure rate (CR) of 100%), while two still excreted Neca-
tor DNA (CR = 75%). Although this was observed in only eight cases, it supports the findings
on the efficacy of ALB to different helminth infections presented by Horton [60] who reported
a notably lower CR for Necator infections (CR = 75%, 30 studies) compared to Ancylostoma
spp. infections (CR = 92%, 23 studies). Given the seemingly differential susceptibility of both
hookworm genera to ALB, it is important to differentiate hookworm infections in order to
have correct efficacy estimates for each species. This is of particular interest when the possible
contribution of zoonotic A. ceylanicum infections from animal reservoirs to the observed drug
efficacy is investigated.
Conclusion
The present study investigated the equivalence of five different diagnostic tools for the evalua-
tion of anthelmintic efficacy. None of the evaluated tests provided equivalent results to those
obtained by the currently recommended single Kato-Katz for all STH, but this might be due to
the number of pairwise-comparisons and the strict bounds of equivalence. Overall, there was
an acceptable agreement in classifying the efficacy of ALB, suggesting that each of the investi-
gated methods holds promise to assess drug efficacy in the context of STH control programs.
The results also highlight that the clinical sensitivity or the ability to accurately estimate egg
counts should not be the only parameters to determine the best diagnostic tool to assess drug
efficacy. Instead, there are a number of other aspects that should also be considered to make a
well-founded decision on what method(s) to recommend for monitoring drug efficacy in STH
control programs, like user-friendliness and operational costs per test. We observed a decreas-
ing trend in drug efficacy as a function of increasing historic drug pressure, yet further
research is needed to identify factors that are contributing to this variation and to determine
whether reduced efficacy can be linked with the known β-tubulin SNPs.
Supporting information
S1 Info. Testing for difference vs. testing for equivalence.
(DOCX)
S2 Info. Number of complete cases per school, sex and age across the four study sites.
(DOCX)
S3 Info. Agreement in classifying the individual response against A. lumbricoides, T. tri-
chiura and hookworm between a single Kato-Katz and duplicate Kato-Katz, Mini-FLO-
TAC, FECPAKG2 and qPCR.
(DOCX)
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 18 / 23
S4 Info. Complete dataset.
(XLSX)
Acknowledgments
First and foremost, the authors would like to express their gratitude towards all children, their
parents, the school teachers and principals that participated in this study. Second, we wish to
specifically thank all the people that provided the necessary laboratory and logistic support in
each of the four different sampling sites. This work would not have been possible without their
willful participation and assistance.
Author Contributions
Conceptualization: Marco Albonico, Jennifer Keiser, Jozef Vercruysse, Bruno Levecke.
Data curation: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Formal analysis: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Funding acquisition: Marco Albonico, Jennifer Keiser, Jozef Vercruysse, Bruno Levecke.
Investigation: Johnny Vlaminck, Piet Cools, Shaali Ame, Mio Ayana, Daniel Dana, Leonardo
F. Matoso, Simone A. Pinto, Somphou Sayasone, Jaco J. Verweij, Bruno Levecke.
Methodology: Johnny Vlaminck, Piet Cools, Mio Ayana, Jennifer Keiser, Jaco J. Verweij,
Bruno Levecke.
Project administration: Bruno Levecke.
Resources: Marco Albonico, Shaali Ame, Mio Ayana, Giuseppe Cringoli, Maria P. Maurelli,
Antonio Montresor, Zeleke Mekonnen, Greg Mirams, Rodrigo Corrêa-Oliveira, Laura
Rinaldi, Somphou Sayasone, Eurion Thomas, Jaco J. Verweij.
Software: Greg Mirams, Eurion Thomas.
Supervision: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Validation: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Visualization: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Writing – original draft: Johnny Vlaminck, Piet Cools, Bruno Levecke.
Writing – review & editing: Johnny Vlaminck, Piet Cools, Marco Albonico, Shaali Ame, Mio
Ayana, Giuseppe Cringoli, Daniel Dana, Jennifer Keiser, Maria P. Maurelli, Leonardo F.
Matoso, Antonio Montresor, Zeleke Mekonnen, Greg Mirams, Rodrigo Corrêa-Oliveira,
Simone A. Pinto, Laura Rinaldi, Somphou Sayasone, Eurion Thomas, Jozef Vercruysse,
Jaco J. Verweij, Bruno Levecke.
References
1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national
incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a sys-
tematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053):1545–602.
https://doi.org/10.1016/S0140-6736(16)31678-6 PMID: 27733282
2. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years
(DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territo-
ries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;
392:1859–922. https://doi.org/10.1016/S0140-6736(18)32335-3 PMID: 30415748
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 19 / 23
3. World Health Organization. Preventive chemotherapy to control soil-transmitted helminth infections in
at-risk population groups. Geneva, Switzerland: World Health Organization, 2017.
4. World Health Organization. Crossing the billion. Lymphatic filariasis, onchocerciasis, schistosomiasis,
soil-transmitted helminthiasis and trachoma: preventive chemotherapy for neglected tropical diseases.
Geneva: World Health Organization, 2017
5. World Health Organization. Soil-transmitted helminthiases: eliminating soil-transmitted helminthiases
as a public healt problem in children: progress report 2001–2010 and strategic plan 2011–2020.
Geneva, Switserland: 2012.
6. World Health Organization. Schistosomiasis and soil-transmitted helminthiases: numbers of people
treated in 2017. Weekly epidemiological record. 2018; 93:681–92.
7. Levecke B, Montresor A, Albonico M, Ame SM, Behnke JM, Bethony JM, et al. Assessment of anthel-
mintic efficacy of mebendazole in school children in six countries where soil-transmitted helminths are
endemic. PLoS Negl Trop Dis. 2014; 8(10):e3204. https://doi.org/10.1371/journal.pntd.0003204 PMID:
25299391
8. Vercruysse J, Behnke JM, Albonico M, Ame SM, Angebault C, Bethony JM, et al. Assessment of the
anthelmintic efficacy of albendazole in school children in seven countries where soil-transmitted hel-
minths are endemic. PLoS Negl Trop Dis. 2011; 5(3):e948. https://doi.org/10.1371/journal.pntd.
0000948 PMID: 21468309
9. Moser W, Schindler C, Keiser J. Efficacy of recommended drugs against soil transmitted helminths:
systematic review and network meta-analysis. BMJ. 2017; 358:j4307. https://doi.org/10.1136/bmj.j4307
PMID: 28947636
10. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic
review and meta-analysis. JAMA. 2008; 299(16):1937–48. https://doi.org/10.1001/jama.299.16.1937
PMID: 18430913
11. Olliaro P, Seiler J, Kuesel A, Horton J, Clark JN, Don R, et al. Potential drug development candidates
for human soil-transmitted helminthiases. PLoS Negl Trop Dis. 2011; 5(6):e1138. https://doi.org/10.
1371/journal.pntd.0001138 PMID: 21695247
12. Keiser J, Utzinger J. The drugs we have and the drugs we need against major helminth infections. Adv
Parasitol. 2010; 73:197–230. https://doi.org/10.1016/S0065-308X(10)73008-6 PMID: 20627144
13. World Health Organization. Assessing the efficacy of anthelminthic drugs against schistosomiasis and
soil-transmitted helminthiases. Geneva, Switserland: World Health Organisation, 2013.
14. Barda BD, Rinaldi L, Ianniello D, Zepherine H, Salvo F, Sadutshang T, et al. Mini-FLOTAC, an innova-
tive direct diagnostic technique for intestinal parasitic infections: experience from the field. PLoS Negl
Trop Dis. 2013; 7(8):e2344. https://doi.org/10.1371/journal.pntd.0002344 PMID: 23936577
15. Cringoli G, Maurelli MP, Levecke B, Bosco A, Vercruysse J, Utzinger J, et al. The Mini-FLOTAC tech-
nique for the diagnosis of helminth and protozoan infections in humans and animals. Nat Protoc. 2017;
12(9):1723–32. https://doi.org/10.1038/nprot.2017.067 PMID: 28771238
16. Moser W, Barenbold O, Mirams GJ, Cools P, Vlaminck J, Ali SM, et al. Diagnostic comparison between
FECPAKG2 and the Kato-Katz method for analyzing soil-transmitted helminth eggs in stool. PLoS Negl
Trop Dis. 2018; 12(6):e0006562. https://doi.org/10.1371/journal.pntd.0006562 PMID: 29864132
17. Ayana M, Vlaminck J, Cools P, Ame S, Albonico M, Dana D, et al. Modification and optimization of the
FECPAKG2 protocol for the detection and quantification of soil-transmitted helminth eggs in human
stool. PLoS Negl Trop Dis. 2018; 12(10):e0006655. https://doi.org/10.1371/journal.pntd.0006655
PMID: 30321180
18. Llewellyn S, Inpankaew T, Nery SV, Gray DJ, Verweij JJ, Clements AC, et al. Application of a multiplex
quantitative PCR to assess prevalence and intensity of intestinal parasite infections in a controlled clini-
cal trial. PLoS Negl Trop Dis. 2016; 10(1):e0004380. https://doi.org/10.1371/journal.pntd.0004380
PMID: 26820626
19. Staudacher O, Heimer J, Steiner F, Kayonga Y, Havugimana JM, Ignatius R, et al. Soil-transmitted hel-
minths in southern highland Rwanda: associated factors and effectiveness of school-based preventive
chemotherapy. Trop Med Int Health. 2014; 19(7):812–24. https://doi.org/10.1111/tmi.12321 PMID:
24750543
20. Verweij JJ, Stensvold CR. Molecular testing for clinical diagnosis and epidemiological investigations of
intestinal parasitic infections. Clin Microbiol Rev. 2014; 27(2):371–418. https://doi.org/10.1128/CMR.
00122-13 PMID: 24696439
21. Barda B, Cajal P, Villagran E, Cimino R, Juarez M, Krolewiecki A, et al. Mini-FLOTAC, Kato-Katz and
McMaster: three methods, one goal; highlights from north Argentina. Parasit Vectors. 2014; 7:271.
https://doi.org/10.1186/1756-3305-7-271 PMID: 24929554
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 20 / 23
22. Mationg MLS, Gordon CA, Tallo VL, Olveda RM, Alday PP, Renosa MDC, et al. Status of soil-transmit-
ted helminth infections in schoolchildren in Laguna Province, the Philippines: Determined by parasito-
logical and molecular diagnostic techniques. PLoS Negl Trop Dis. 2017; 11(11):e0006022. https://doi.
org/10.1371/journal.pntd.0006022 PMID: 29108026
23. Easton AV, Oliveira RG, O’Connell EM, Kepha S, Mwandawiro CS, Njenga SM, et al. Multi-parallel
qPCR provides increased sensitivity and diagnostic breadth for gastrointestinal parasites of humans:
field-based inferences on the impact of mass deworming. Parasit Vectors. 2016; 9:38. https://doi.org/
10.1186/s13071-016-1314-y PMID: 26813411
24. Papaiakovou M, Pilotte N, Grant JR, Traub RJ, Llewellyn S, McCarthy JS, et al. A novel, species-spe-
cific, real-time PCR assay for the detection of the emerging zoonotic parasite Ancylostoma ceylanicum
in human stool. PLoS Negl Trop Dis. 2017; 11(7):e0005734. https://doi.org/10.1371/journal.pntd.
0005734 PMID: 28692668
25. Verweij JJ. Application of PCR-based methods for diagnosis of intestinal parasitic infections in the clini-
cal laboratory. Parasitology. 2014; 141(14):1863–72. https://doi.org/10.1017/S0031182014000419
PMID: 24780241
26. O’Connell EM, Nutman TB. Molecular Diagnostics for soil-transmitted helminths. Am J Trop Med Hyg.
2016; 95(3):508–13. https://doi.org/10.4269/ajtmh.16-0266 PMID: 27481053
27. Verweij JJ, Brienen EA, Ziem J, Yelifari L, Polderman AM, Van Lieshout L. Simultaneous detection and
quantification of Ancylostoma duodenale, Necator americanus, and Oesophagostomum bifurcum in
fecal samples using multiplex real-time PCR. Am J Trop Med Hyg. 2007; 77(4):685–90. PMID:
17978072
28. Hoekendijk DJ, Hill PC, Sowerby SJ. Rationale for quality assurance in fecal egg monitoring of soil-
transmitted helminthiasis. Am J Trop Med Hyg. 2016; 95(3):502–4. https://doi.org/10.4269/ajtmh.15-
0463 PMID: 27352875
29. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: mini-
mum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009; 55
(4):611–22. https://doi.org/10.1373/clinchem.2008.112797 PMID: 19246619
30. Kaisar MMM, Brienen EAT, Djuardi Y, Sartono E, Yazdanbakhsh M, Verweij JJ, et al. Improved diagno-
sis of Trichuris trichiura by using a bead-beating procedure on ethanol preserved stool samples prior to
DNA isolation and the performance of multiplex real-time PCR for intestinal parasites. Parasitology.
2017; 144(7):965–74. https://doi.org/10.1017/S0031182017000129 PMID: 28290266
31. Easton AV, Oliveira RG, Walker M, O’Connell EM, Njenga SM, Mwandawiro CS, et al. Sources of vari-
ability in the measurement of Ascaris lumbricoides infection intensity by Kato-Katz and qPCR. Parasit
Vectors. 2017; 10(1):256. https://doi.org/10.1186/s13071-017-2164-y PMID: 28545561
32. Barda B, Albonico M, Ianniello D, Ame SM, Keiser J, Speich B, et al. How long can stool samples be
fixed for an accurate diagnosis of soil-transmitted helminth infection using Mini-FLOTAC? PLoS Negl
Trop Dis. 2015; 9(4):e0003698. https://doi.org/10.1371/journal.pntd.0003698 PMID: 25848772
33. Krucken J, Fraundorfer K, Mugisha JC, Ramunke S, Sifft KC, Geus D, et al. Reduced efficacy of alben-
dazole against Ascaris lumbricoides in Rwandan schoolchildren. Int J Parasitol Drugs Drug Resist.
2017; 7(3):262–71. https://doi.org/10.1016/j.ijpddr.2017.06.001 PMID: 28697451
34. Vaz Nery S, Qi J, Llewellyn S, Clarke NE, Traub R, Gray DJ, et al. Use of quantitative PCR to assess
the efficacy of albendazole against Necator americanus and Ascaris spp. in Manufahi District, Timor-
Leste. Parasit Vectors. 2018; 11(1):373. https://doi.org/10.1186/s13071-018-2838-0 PMID: 29954461
35. Vlaminck J, Cools P, Albonico M, Ame S, Ayana M, Bethony J, et al. Comprehensive evaluation of
stool-based diagnostic methods and benzimidazole resistance markers to assess drug efficacy and
detect the emergence of anthelmintic resistance: A Starworms study protocol. PLoS Negl Trop Dis.
2018; 12(11):e0006912. https://doi.org/10.1371/journal.pntd.0006912 PMID: 30388108
36. Bethony J, Brooker S, Albonico M, Geiger SM, Loukas A, Diemert D, et al. Soil-transmitted helminth
infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006; 367(9521):1521–32. https://doi.org/
10.1016/S0140-6736(06)68653-4 PMID: 16679166
37. Starworms.org. The starworms project website. Available from: https://www.starworms.org/. [cited
2019 Jan 24]
38. R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statis-
tical Computing, Vienna, Australia: URL https://www.R-project.org/.
39. Cools P, Vlaminck J, Albonico M, Ame S, Ayana M, Cringoli G, et al. Diagnostic performance of qPCR,
Kato-Katz thick smear, Mini-FLOTAC and FECPAKG2 for the detection and quantification of soil-trans-
mitted helminths in three endemic countries. PLoS Negl Trop Dis. Forthcoming 2019.
40. Levecke B, Dobson RJ, Speybroeck N, Vercruysse J, Charlier J. Novel insights in the faecal egg count
reduction test for monitoring drug efficacy against gastrointestinal nematodes of veterinary importance.
Vet Parasitol. 2012; 188(3–4):391–6. https://doi.org/10.1016/j.vetpar.2012.03.020 PMID: 22521979
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 21 / 23
41. Levecke B, Anderson RM, Berkvens D, Charlier J, Devleesschauwer B, Speybroeck N, et al. Mathemat-
ical inference on helminth egg counts in stool and its applications in mass drug administration pro-
grammes to control soil-transmitted helminthiasis in public health. Adv Parasitol. 2015; 87:193–247.
https://doi.org/10.1016/bs.apar.2015.01.001 PMID: 25765196
42. Levecke B, De Wilde N, Vandenhoute E, Vercruysse J. Field validity and feasibility of four techniques
for the detection of Trichuris in simians: a model for monitoring drug efficacy in public health? PLoS
Negl Trop Dis. 2009; 3(1):e366. https://doi.org/10.1371/journal.pntd.0000366 PMID: 19172171
43. Bekana T, Mekonnen Z, Zeynudin A, Ayana M, Getachew M, Vercruysse J, et al. Comparison of Kato-
Katz thick-smear and McMaster egg counting method for the assessment of drug efficacy against soil-
transmitted helminthiasis in school children in Jimma Town, Ethiopia. Trans R Soc Trop Med Hyg.
2015; 109(10):669–71. https://doi.org/10.1093/trstmh/trv073 PMID: 26385937
44. Levecke B, Behnke JM, Ajjampur SS, Albonico M, Ame SM, Charlier J, et al. A comparison of the sensi-
tivity and fecal egg counts of the McMaster egg counting and Kato-Katz thick smear methods for soil-
transmitted helminths. PLoS Negl Trop Dis. 2011; 5(6):e1201. https://doi.org/10.1371/journal.pntd.
0001201 PMID: 21695104
45. Levecke B, Brooker SJ, Knopp S, Steinmann P, Sousa-Figueiredo JC, Stothard JR, et al. Effect of sam-
pling and diagnostic effort on the assessment of schistosomiasis and soil-transmitted helminthiasis and
drug efficacy: a meta-analysis of six drug efficacy trials and one epidemiological survey. Parasitol.
2014; 141(14):1826–40.
46. Kenyon F, Rinaldi L, McBean D, Pepe P, Bosco A, Melville L, et al. Pooling sheep faecal samples for
the assessment of anthelmintic drug efficacy using McMaster and Mini-FLOTAC in gastrointestinal
strongyle and Nematodirus infection. Vet Parasitol. 2016; 225:53–60. https://doi.org/10.1016/j.vetpar.
2016.03.022 PMID: 27369575
47. Rinaldi L, Levecke B, Bosco A, Ianiello D, Pepe P, Charlier J, et al. Comparison of individual and pooled
faecal samples in sheep for the assessment of gastrointestinal strongyle infection intensity and anthel-
mintic drug efficacy using McMaster and Mini-FLOTAC. Vet Parasitol. 2014; 205(1–2):216–23 https://
doi.org/10.1016/j.vetpar.2014.06.011 PMID: 25002307
48. Levecke B, Mekonnen Z, Albonico M, Vercruysse J. The impact of baseline faecal egg counts on the
efficacy of single-dose albendazole against Trichuris trichiura. Trans R Soc Trop Med Hyg. 2012; 106
(2):128–30. https://doi.org/10.1016/j.trstmh.2011.09.007 PMID: 22189084
49. Walker M, Mabud TS, Olliaro PL, Coulibaly JT, King CH, Raso G, et al. New approaches to measuring
anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment
with praziquantel. Parasit Vectors. 2016; 9:41. https://doi.org/10.1186/s13071-016-1312-0 PMID:
26813154
50. Diawara A, Schwenkenbecher JM, Kaplan RM, Prichard RK. Molecular and biological diagnostic tests
for monitoring benzimidazole resistance in human soil-transmitted helminths. Am J Trop Med Hyg.
2013; 88(6):1052–61. https://doi.org/10.4269/ajtmh.12-0484 PMID: 23458960
51. Diawara A, Halpenny CM, Churcher TS, Mwandawiro C, Kihara J, Kaplan RM, et al. Association
between response to albendazole treatment and beta-tubulin genotype frequencies in soil-transmitted
helminths. PLoS Negl Trop Dis. 2013; 7(5):e2247. https://doi.org/10.1371/journal.pntd.0002247 PMID:
23738029
52. Diawara A, Drake LJ, Suswillo RR, Kihara J, Bundy DA, Scott ME, et al. Assays to detect beta-tubulin
codon 200 polymorphism in Trichuris trichiura and Ascaris lumbricoides. PLoS Negl Trop Dis. 2009; 3
(3):e397. https://doi.org/10.1371/journal.pntd.0000397 PMID: 19308251
53. Schwenkenbecher JM, Albonico M, Bickle Q, Kaplan RM. Characterization of beta-tubulin genes in
hookworms and investigation of resistance-associated mutations using real-time PCR. Mol Biochem
Parasitol. 2007; 156(2):167–74. https://doi.org/10.1016/j.molbiopara.2007.07.019 PMID: 17850900
54. Albonico M, Wright V, Bickle Q. Molecular analysis of the beta-tubulin gene of human hookworms as a
basis for possible benzimidazole resistance on Pemba Island. Mol Biochem Parasitol. 2004; 134
(2):281–4. https://doi.org/10.1016/j.molbiopara.2003.12.008 PMID: 15003848
55. Orr AR, Quagraine JE, Suwondo P, George S, Harrison LM, Dornas FP, et al. Genetic markers of benz-
imidazole resistance among human hookworms (Necator americanus) in Kintampo north municipality,
Ghana. Am J Trop Med Hyg. 2018; in press.
56. Soukhathammavong PA, Sayasone S, Phongluxa K, Xayaseng V, Utzinger J, Vounatsou P, et al. Low
efficacy of single-dose albendazole and mebendazole against hookworm and effect on concomitant hel-
minth infection in Lao PDR. PLoS Negl Trop Dis. 2012; 6(1):e1417. https://doi.org/10.1371/journal.pntd.
0001417 PMID: 22235353
57. Humphries D, Nguyen S, Kumar S, Quagraine JE, Otchere J, Harrison LM, et al. Effectiveness of alben-
dazole for hookworm varies widely by community and correlates with nutritional factors: a cross-
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 22 / 23
sectional study of school-age children in Ghana. Am J Trop Med Hyg. 2017; 96(2):347–54. https://doi.
org/10.4269/ajtmh.16-0682 PMID: 27895280
58. Levecke B, Easton AV, Cools P, Albonico M, Ame S, Gilleard JS, et al. The optimal timing of post-treat-
ment sampling for the assessment of anthelminthic drug efficacy against Ascaris infections in humans.
Int J Parasitol Drugs Drug Resist. 2018; 8(1):67–9. https://doi.org/10.1016/j.ijpddr.2017.12.004 PMID:
29414108
59. Albonico M, Stoltzfus RJ, Savioli L, Tielsch JM, Chwaya HM, Ercole E, et al. Epidemiological evidence
for a differential effect of hookworm species, Ancylostoma duodenale or Necator americanus, on iron
status of children. Int J Epidemiol. 1998; 27(3):530–7. https://doi.org/10.1093/ije/27.3.530 PMID:
9698148
60. Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000; 121
Suppl:S113–32.
Efficacy of albendazole evaluated by five diagnostic methods
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007471 August 1, 2019 23 / 23
